Objectives: To study whether in-vivo recruitment of dendritic cells in response to antigen administration in the skin is altered during HIV-1 infection.
Introduction
Dendritic cells are the foremost initiators of adaptive immune responses. They prime and condition T cells and are, therefore, critical for cellular immunity. The major human dendritic cell subtypes are the CD11c þ myeloid dendritic cells (MDCs) and CD123 þ plasmacytoid dendritic cells (PDCs). Both MDCs and PDCs are susceptible to HIV-1 infection, although they are poor hosts for viral replication [1] [2] [3] [4] [5] [6] . The frequency of infected dendritic cells in vivo is undetectable or very low compared to CD4 þ T cells, at least after initial transmission [7] [8] [9] . It is well documented that the numbers of blood MDCs and PDCs are reduced in HIV-1-positive individuals [10] [11] [12] [13] [14] but whether this is due to depletion resulting from direct infection or immune exhaustion, or anatomical redistribution, is largely unknown [15] [16] [17] . The decline in circulating dendritic cells correlates with an increase in HIV-1 viral load, suggesting that there is an inverse relationship between the loss of dendritic cells and control of the disease. However, whether dendritic cells are functionally defective in HIV-1-infected individuals to a degree that would affect the priming or re-activation of antigenspecific immune responses is not understood.
Skin-resident dendritic cells are almost exclusively of the MDC lineage. However, PDCs that do not usually reside in the skin have recently been shown to infiltrate skin lesions caused by herpes and varicella infections, and the level of PDC recruitment to the lesions was shown to correlate with control of infection [18] [19] [20] [21] . In addition, we earlier demonstrated that there is a robust infiltration of several distinct dendritic cell subsets including PDCs into dermal indurations induced by the tuberculin skin test (TST) [22] . The level of recruitment of functionally different dendritic cell subsets to sites of antigen exposure is likely to shape the quality and magnitude of the adaptive response. In this study, we asked whether the recruitment of different dendritic cell subsets in vivo in response to antigen skin testing is affected during HIV-1 infection. We utilized widely employed clinical skin tests in which antigens are injected intradermally for evaluation of previous antigen exposure or integrity of the cellular immune system. These tests can, for example, be based on injection of inactivated mumps virus, Candida albicans antigens, or purified protein derivate (PPD) from Mycobacterium tuberculosis. In sensitized individuals, a delayed-type hypersensitivity (DTH) reaction appears at the injection site as a consequence of accumulation of T cells, which are presumably antigen-specific. The immune reaction is likely initiated by antigen uptake by skin dendritic cells and subsequent presentation to antigen-specific memory T cells [23, 24] . T cells homing to and accumulating at the antigen site then drive the immune reaction, which in turn leads to inflammation, causing a visible skin induration in sensitized individuals. To study infiltration of dendritic cells and T cells in response to antigen injection, skin punch biopsies were collected at 48 h from such indurations in cohorts of healthy individuals as well as HIV-1-positive individuals. We found a large infiltration of several dendritic cell subsets. This was accompanied by infiltration of T cells, which were found in clusters with dendritic cells in the dermis. The frequencies of dendritic cells at the antigeninjected sites were significantly lower in HIV-1-positive individuals compared to healthy controls in response to PPD and mumps antigens but not to C. albicans. The levels of dendritic cell infiltration reflected the frequencies of T cells at the respective sites. Hence, there seemed to be sufficient numbers of dendritic cells available to be mobilized when the antigen response/inflammatory milieu was adequate. The level of dendritic cell infiltration in this cognate antigen exposure model may, therefore, instead be determined by the levels of responding antigen-specific memory T cells that home to the antigen site. A depleted or deficient T-cell compartment could, therefore, lead to compromised dendritic cell recruitment and insufficient antigen presentation to T cells.
Participants and methods

Study cohorts
Written informed consent was obtained from all study participants. The Institutional Review Boards of Ethics at the respective research institutes approved this study. The cohort that received the TSTwas recruited in Khayelitsha Township, Cape Town, South Africa. The criteria for study enrollment were described earlier [25] . Healthy seronegative and untreated HIV-1-positive asymptomatic individuals, with CD4 cell counts of mean AE SEM 579 AE 82/ml blood, were matched by age, sex, and size of the TST induration (Table 1) . A group of individuals with AIDS, with CD4 cell counts of 150 AE 8.9/ml blood, was included for comparison. TST was performed according to international standards and considered positive at 10 mm. All study participants except two of the AIDS patients, displayed positive TST reactions (18.6 AE 2.3 mm). Punch biopsies were taken as described [26] from the PPD injection site and a saline-injected site on the opposite arm at 48 h after injection and snap frozen.
Other study cohorts were recruited by the University Hospital of Cleveland, Ohio, USA. They received mumps skin test antigen (MSTA) and C. albicans skin test antigen (CASTA), and consisted of seronegative healthy individuals, asymptomatic untreated HIV-1positive individuals with CD4 cell counts of 690 AE 72/ ml and HIV-1 RNA copies of 1667 AE 1036/ml, and individuals with AIDS with CD4 cell counts of 27 AE 13/ ml and HIV-1 RNA copies of more than 750 000/ml. All donors had positive indurations as defined by 5 mm. The indurations in the seronegative controls were 14.8 AE 3.2 mm for MSTA and 10 AE 2.8 mm for CASTA, whereas HIV-1-positive asymptomatic individuals had indurations of 9.7 AE 1.7 and 13 AE 1 mm, respectively. AIDS patients had 9 AE 3 mm. As above, punch biopsies were collected 48 h after injection.
Immunohistochemical staining and quantitative image analysis
Sections from skin biopsies (8 mm) were stained as described [15, 27] with anti-CD11c, CD123, and Ki67 (BD Biosciences, San José, California, USA), CD3, CD45RO, CD45RA (Dako, Glostrup, Denmark), CD303 (BDCA-2), DC-SIGN, Langerin (R&D Systems, Minneapolis, Minnesota, USA), CD141 (BDCA-3; Miltenyi Biotech, Auburn, California, USA), DNGR-1 (Dr Reis e Sousa, London Research Institute) followed by the antimouse, antigoat (Dako), or antirabbit (Vector Laboratories, Burlingame, California, USA) biotinylated secondary antibodies (Abs). The peroxidase system, Vectastain Elite ABC kit together with substrate diaminobenzidine tetrahydrochloride (Vector Laboratories) was used to label the secondary Abs. Cell nuclei were counterstained with Mayer's Hematoxylin (Histolab Products, Gothenburg, Sweden). A blinded analysis of the sections was performed by two separate investigators with a Leica DMR-X microscope (Leica Microsystems GmbH, Wetzlar, Germany) coupled to computerized image analysis (Leica Qwin 5501W; Leica Imaging Systems) as described [22] . Quantification of all markers was performed in the dermis except for Langerin, which was done in the epidermis. Melanin-rich cells at the interface of the epidermis and the dermis were excluded from the analyses. All scale bars represent 25 um.
Fluorescent costaining
Staining procedures were performed as above, except the secondary biotinylated Abs, were detected by Alexa488conjugated or Alexa647-conjugated streptavidin (Molecular Probes, Eugene, Oregon, USA), and anti-CD4 and anti-CD8 (BD) were also included. Sections were mounted using SlowFade Gold Antifade Reagent with DAPI 4 0 ,6 0 -diamidino-2-phenylindole (Life Technologies, Stockholm, Sweden).
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Statistical analyses
Data were analyzed by Student's t-test except Ki67 and DNGR-1, which was assessed with Mann-Whitney test using GraphPad Prism software (GraphPad Prism software Inc., San Diego, California, USA), and considered significant at Ã P 0.05, ÃÃ P 0.01, and ÃÃÃ P 0.001. Correlation analyses were done using the same software.
Results
Reduced dendritic cell accumulation in tuberculin skin test indurations in HIV-1-positive individuals
In this study, we used the antigen skin test model to evaluate whether HIV-1-positive individuals show impaired dendritic cell recruitment in vivo in response to antigen exposure and inflammation compared to healthy individuals. As expected, in healthy individuals, there was a clear infiltration of cells expressing human leukocyte antigen-DR as found by an increase in the percentage of stained area out of the total dermal sample area in biopsies from the TST indurations compared to the donor-matched saline-injected control sites ( Fig. 1 ).
In addition, expression of the MDC marker CD11c was found to be significantly higher in the TSTreaction than in control sites ( Fig. 1a-b , P < 0.0001). In controls, the majority of CD11c þ cells were typically present in clusters in the dermis, whereas the CD11c þ cells in the TST reaction were scattered throughout the dermis. PDCs, defined by CD123 and CD303 (BDCA-2) expression, were rare or absent in the controls, but consistently present in clusters in the dermis of the TST sites ( Fig. 1a-b , P ¼ 0.030 and P ¼ 0.0002, for CD123 and CD303 respectively). CD141 (BDCA-3), recently reported to define a distinct MDC subset with superior crosspresenting function [28] , was expressed at very low levels in the controls but was detected in all the TST biopsies ( Fig. 1a-b , P ¼ 0.002). Also, DNGR-1, a receptor that contributes to the cross-presenting capacity of this subset [28] , was significantly more prevalent at the TST sites compared to control sites ( Fig. 1b , P ¼ 0.024). The C-type lectin receptors (CLRs) DC-SIGN and Langerin, were also significantly more highly expressed in the TSTreaction compared to the control ( Fig. 1 , P 0.005 and P ¼ 0.015, respectively). All these markers were almost exclusively expressed in the dermis except for Langerin, which was expressed on Langerhans cells in the epidermis.
There was no difference in the percentage of area expressing dendritic cell markers in the saline-injected control sites between the seronegative and the HIV-1positive asymptomatic individuals. Thus, the well documented reduction in numbers of blood dendritic cells during HIV-1 infection was not apparent among skin-resident dendritic cells. In contrast, the levels of CD11c (P ¼ 0.002), CD141 (P ¼ 0.039), and CD303 (P ¼ 0.029) expression in the TST reaction were significantly lower in the HIV-1-positive asymptomatic individuals compared to healthy controls ( Fig. 1a-b ). In addition, there was a noticeably lower accumulation of the rest of the dendritic cell markers in the TST reaction of the HIV-1-positive individuals. Also, except for DC-SIGN, all dendritic cell markers were expressed at even lower levels at the TST sites of the AIDS patients.
Level of T-cell accumulation at the tuberculin skin test reaction site correlates with dendritic cell infiltration In the TST indurations, CD3 þ T cells were found exclusively in the dermis, in cluster formations with dendritic cell markers such as CD11c and CD123 ( Fig. 2a-b ). There was an increased infiltration of CD3 þ T cells in the TST reactions compared to the saline-injected sites of both the seronegative and the HIV-1-positive individuals (Fig. 2c ), but the infiltration was significantly higher in the seronegative controls (P ¼ 0.0039). There was a significant correlation between the frequencies of CD3 þ T cells at the TST site and the levels of infiltrating CD123 þ CD303 þ PDCs (Fig. 2d ) and CD11c þ MDCs with a trend for the CD141 þ MDCs (Fig. 2e ). The healthy controls showed the highest levels of both CD3 þ T-cell and dendritic cell infiltration, followed by the asymptomatic HIV-1-positive individuals. The patients with AIDS had the lowest degree of cell infiltration. Both CD4 þ and CD8 þ T cells were found to be recruited to the TST sites ( Fig. 2f-g) . In contrast to the cell numbers, Ki67 expression in the T cells, indicating cell cycling, was almost exclusively found in the HIV-1positive individuals, especially those with AIDS ( Fig. 2h-j) .
Differential recruitment of dendritic cells in response to mumps and Candida albicans antigen injection As significantly lower frequencies of both dendritic cells and T cells infiltrated the TST site in HIV-1-positive individuals compared to healthy controls, we asked whether this was due to cell depletion and/or due to a general immune defect including a reduced ability of the cells to migrate toward antigen exposure/inflammation. To investigate whether the recruitment was antigenspecific or general to DTH reactions, we established new cohorts that received clinical skin antigen tests based on inactivated sterilized mumps virus or C. albicans (Table 1) . As for TST, both of these skin tests stimulate DTH reactions and most adults respond with indurations as they have been vaccinated against or infected with mumps virus, and are constantly exposed to C. albicans as a commensal fungus. All donors included in the study had positive indurations.
MDC subsets expressing CD11c and/or CD141 as well as PDCs expressing CD303 accumulated at sites injected with mumps or C. albicans in healthy controls as well as in HIV-1-positive individuals. As these cohorts contained fewer individuals, fewer comparisons reached statistically significant differences. However, there appeared to be a trend that the levels of infiltrating dendritic cells were higher in the healthy controls compared to the HIV-1positive individuals in response to mumps (Fig. 3a-c) . Conversely, the dendritic cell recruitment in response to C. albicans was higher in the HIV-1-positive individuals compared to the healthy controls. As there was a differential pattern of dendritic cell infiltration to mumps versus C. albicans, we speculated that the magnitude of memory T cells specific for the respective antigens might determine the level of dendritic cell recruitment. High C. albicans-specific T-cell responses have been reported in HIV-1-positive patients compared to seronegative controls [29] [30] [31] . In line with these data, the mean induration sizes after C. albicans antigen test were larger in the HIV-1-positive groups and we found significantly higher levels of infiltrating CD3 þ T cells in the indurations of the HIV-1-positive individuals compared to seronegative controls ( Fig. 3d ; P ¼ 0.001). The frequencies of T cells at the C. albicans site were also higher than in the donor-matched mumps site in the HIV-1-positive asymptomatic individuals, which was not the case in the controls. Thus, as found for TSTs, the CD3 data aligned with the levels of infiltrating dendritic cells in the C. albicans skin test sites. The level of T-cell accumulation at the antigen site, which is presumably dictated by the preexisting pool of antigenspecific memory cells in the donors, may therefore regulate the level of inflammation that in turn controls the level of dendritic cell recruitment. Intrinsic differences in the characteristics of the antigens in the tests may also play a role in the recruitment of dendritic cells. However, the tests are designed to only stimulate cellular immune responses in sensitized individuals, which is why the indurations should be greatly dependent on memory T cells. Consistent with the data in the TST group, the frequencies of Ki67 þ cells in mumps indurations and in particular C. albicans indurations were higher in the HIV-1-positive individuals (Fig. 3e ). This is in accordance with that HIV-1 infection is associated with chronic immune activation including increased level of cycling T cells in peripheral blood [32] . CD45RO was expressed at higher levels than CD45RA at the sites ( Fig. 3f-g ). Although these are crude marker for phenotyping T cells, this suggests that the majority of infiltrating T cells are cycling memory T cells.
Discussion
Skin testing is a widely employed and readily available method of clinically assessing the cellular immune response. A positive skin test reaction indicates previous antigenic exposure, T-cell competence, and an intact inflammatory response. In accordance with the fact that the skin test formulations exclusively induce immune activation in individuals with preexisting immunity, we have earlier reported that there is no infiltration of dendritic cells after injection of PPD in nonsensitized individuals who do not display positive TST indurations [22] . The efficiency with which skin test antigen is presented to T cells and with which the DTH reaction develops are likely strongly enhanced by the level of recruitment of dendritic cells to the skin and continuous antigen presentation [23, 24, 33] . Thus, although the initial dendritic cells that take up antigen after skin test injection, and migrate and present to T cells in draining lymph nodes, may be limited, the subsequent wave of activated T cells homing to the antigen site will cause inflammation which is likely what drives the recruitment of the burst of dendritic cells found at the test site in sensitized individuals. On the basis of the data presented in this study, we conclude that the level of dendritic cell infiltration correlates with the magnitude of T cells infiltrating the site, and hypothesize that the level of dendritic cell recruitment is determined by the frequencies of antigen-specific T cells in the donor. An immunecompromised T-cell compartment could, therefore, lead to insufficient dendritic cell mobilization, which may further attenuate the cellular responses by limiting antigen-presenting capacity at the site.
Several studies have demonstrated that there is a clear loss of blood PDCs and MDCs during HIV-1 infection. In contrast, there is some controversy regarding functional deficiencies of dendritic cells in HIV-1 infection. In order to study dendritic cell function in vivo during HIV-1 infection, we used the antigen skin test as a model to evaluate dendritic cell mobilization following antigen exposure and inflammation. In saline-injected control skin, we did not observe any difference in the numbers of dendritic cells between HIV-1-positive individuals and seronegative individuals. There was, thus, no clear depletion of skin-resident dendritic cells as described for circulating dendritic cells during HIV-1 infection. This is supported by data from larger cohorts of patients that have shown that HIV-1 disease progression is not associated with a decline in epidermal Langerhans cell numbers [34] . Skin dendritic cells are susceptible to HIV-1 infection [35, 36] but do not likely represent a significant viral reservoir [37, 38] . In the skin test model studied here, the infiltrating dendritic cells are presumably mobilized from the blood into the skin. Although data on blood dendritic cell counts in our cohorts were not available, it is likely that the HIV-1-positive asymptomatic individuals had a mild reduction of blood dendritic cell numbers and the AIDS patients had a quite pronounced depletion according to previous reports [13, 39] . We detected lower numbers of infiltrating dendritic cells in response to PPD and mumps injections in the HIV-1-positive individuals, including those with AIDS, compared to the healthy controls. In marked contrast, the dendritic cell infiltration in response to C. albicans was similar or higher in people with HIV-1, indicating that dendritic cell numbers and their mobilization capacity were sufficient at least in the individuals with chronic asymptomatic HIV-1 infection. We interpret the lower infiltration of dendritic cells in response to PPD and mumps than to C. albicans in the HIV-1-positive individuals to be a consequence of the respective levels of memory T-cell responses to these antigens. HIV-1positive individuals have been shown to have higher antigen recall T-cell responses [40, 41] and larger skin indurations to C. albicans compared to PPD and mumps [42] . The fact that an individual can show different levels of T-cell recruitment depending on the type of skin antigen test might explain why DTH anergy has been shown to not necessarily correlate to CD4 cell count or degree of viremia [43] . The integrity of the memory T-cell compartment specific for a given antigen is probably the more important determinant for the ability to respond to a skin test. In our study, even the AIDS patients who had severely reduced CD4 cell counts were able to mount a DTH response in the C. albicans test. As it is a commensal fungus, the host is constantly exposed to C. albicans antigens. In HIV-1 infection, the associated compromised integrity of the gut may facilitate translocation of C. albicans as has been shown for endotoxin [44] . In fact, fungal cell wall products [45, 46] as well as C. albicans-specific Abs [47] are elevated in the serum of HIV-1-positive individuals. This constant exposure to C. albicans may maintain the elevated T-cell responses and explain the increased levels of infiltrating CD3 þ T cells that we observed in response to the C. albicans skin test in the HIV-1-positive group compared to the controls. In contrast, weaker T-cell responses in HIV-1-positive individuals have been described for several viral antigens compared to C. albicans-responses [30] . Also, it has been shown that PPDspecific T cells are preferentially depleted in HIV-1 infection compared to T cells specific for other antigens, which could contribute to lower T-cell accumulation at the TST site [48] . On another note, we cannot rule out that the differential dendritic cell and T-cell recruitment to the different skin antigen tests also relates to different kinetics of their respective immune responses. Analyses of biopsies taken at other time points would provide valuable information on this. However, these tests are clinically well validated with a common evaluation time point at 48 h, which is a time when the DTH indurations peak.
Conclusion
In conclusion, our data, based on limited numbers of study participants, indicate that there is no obvious depletion or deficiency in mobilization of dendritic cells to antigen skin tests in individuals with chronic HIV-1 infection as long as T-cell responses are present. In nonhuman primate models, dendritic cell mobilization from skin to lymph nodes has been shown to be intact in early simian immunodeficiency virus infection but impaired in AIDS, which restricted the numbers of antigen-bearing dendritic cells reaching the lymph nodes and in turn hampered stimulation of antigen-specific T cells [49] . A depleted or deficient T-cell compartment, as in AIDS, may compromise the stimulation of dendritic cells to either be recruited to the antigen skin test site or further mobilize to lymph nodes to present antigens to T cells. Therefore, even if dendritic cells are not a cell type that is directly affected by HIV-1 to any great extent, a collapsing immune milieu will render dendritic cells inept, which further intensifies the cellular immune deficiencies.
